Aztron Medtech’s TendMIN system has been used in more than 100 clinical cases, the company said in a Feb. 5 news release.
TendMIN is designed for percutaneous Achilles tendon repair through an incision of 1 centimeter or less. Brian Burgess, DPM, performed the milestone 100th case.
TendMIN earned FDA listing in 2025, and the company is continuing to expand surgeon training for the device.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.